Skip to Main Content

Author Details

Vipul Jairath
Schulich school of Medicine, Western University.
2007
336
44
PMIDPaper TitleJournal TitlePublished Year
37002875Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysis.Inflamm Bowel Dis2024
37716619Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis.Clin Gastroenterol Hepatol2024
37524088Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials.Inflamm Bowel Dis2024
37523157Defining Magnetic Resonance Imaging Treatment Response and Remission in Crohn's Disease: A Systematic Review.J Crohns Colitis2024
37704112Standardizing Randomized Controlled Trials in Celiac Disease: An International Multidisciplinary Appropriateness Study.Gastroenterology2024
37951560ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse.Clin Gastroenterol Hepatol2024
37949249Integrating Evidence to Guide Use of Biologics and Small Molecules for Inflammatory Bowel Diseases.Gastroenterology2024
37743037Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER).Clin Gastroenterol Hepatol2024
37743039Washout Periods in Inflammatory Bowel Disease Trials: A Systematic Literature Review and Proposed Solutions.Clin Gastroenterol Hepatol2024
37933849Pharmacological Therapies for the Management of Fistulizing Crohn's Disease: A Systematic Review and Meta-Analysis.J Crohns Colitis2024
37186256Matching-adjusted Indirect Comparisons vs Propensity Score Matching with Individual Patient-level Data to Estimate Treatment Efficacy.Inflamm Bowel Dis2024
35944832Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.Clin Gastroenterol Hepatol2023
37799456Advanced Combination Treatment With Biologic Agents and Novel Small Molecule Drugs for Inflammatory Bowel Disease.Gastroenterol Hepatol (N Y)2023
38070932Use of external control arms in immune-mediated inflammatory diseases: a systematic review.BMJ Open2023
37589567Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration.Inflamm Bowel Dis2023
38056798Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn's Disease Activity.Clin Gastroenterol Hepatol2023
37993033Effects of Mirikizumab on Histologic Resolution of Crohn's Disease in a Randomized Controlled Phase 2 Trial.Clin Gastroenterol Hepatol2023
37578211A Comparison of Treatment Effect Sizes in Matched Phase 2 and Phase 3 Trials of Advanced Therapeutics in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.Clin Transl Gastroenterol2023
38034882Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance Studies.Crohns Colitis 3602023
35840062Revisiting Triggers: Optimal Thresholds for Transfusion in Gastrointestinal Bleeding May Be Higher Than Restrictive Guidelines.Clin Gastroenterol Hepatol2023
35762666The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn's Disease.Inflamm Bowel Dis2023
35851799Clinical, Endoscopic, and Radiological Effectiveness of Ustekinumab in Bio-naïve Versus Bio-experienced Patients With Crohn's Disease: Real-world Experience From a Large Canadian Center.Inflamm Bowel Dis2023
37257687Effect of storage time on peripheral blood mononuclear cell isolation from blood collected in vacutainer CPTâ¿¢ tubes.J Immunol Methods2023
37057827Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programmes.J Crohns Colitis2023
37317532Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.J Crohns Colitis2023
37119375Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study.Dig Dis Sci2023
36988594Vedolizumab for the Treatment of Chronic Pouchitis.N Engl J Med2023
37080261Endoscopy Unit Level Interventions to Improve Adenoma Detection Rate: A Systematic Review and Meta-Analysis.Clin Gastroenterol Hepatol2023
37410920Long Washout Periods Between Biologics for Inflammatory Bowel Disease Clinical Trials Are Unnecessary: A Canadian Retrospective Cohort Study.Am J Gastroenterol2023
37246609Systematic review and meta-analysis of randomised controlled trials: Medical therapies for the treatment and prevention of pouchitis.Aliment Pharmacol Ther2023
37180309Extended delay in endoscopic mucosal resection is not associated with adverse outcomes: Findings from the COVID-19 pandemic.Endosc Int Open2023
36976548Comparative Speed of Early Symptomatic Remission With Advanced Therapies for Moderate-to-Severe Ulcerative Colitis: A Systematic Review and Network Meta-Analysis.Am J Gastroenterol2023
37378711Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn's Disease: Systematic Review and Meta-Analysis.Dig Dis Sci2023
37308036Standardizing Scoring Conventions for Crohn's Disease Endoscopy: An International RAND/UCLA Appropriateness Study.Clin Gastroenterol Hepatol2023
37207296Early Remission With Induction Therapy Predicts Long-Term Remission in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.Am J Gastroenterol2023
37439089Informative cluster size in cluster-randomised trials: A case study from the TRIGGER trial.Clin Trials2023
37465925Mirikizumab for the treatment of moderate to severe ulcerative colitis.Immunotherapy2023
37001911Changes in health-related quality of life and associations with improvements in clinical efficacy: a Phase 2 study of mirikizumab in patients with ulcerative colitis.BMJ Open Gastroenterol2023
37266801Targeting IL-23 for IBD: Rationale and Progress to Date.Drugs2023
37164113Epidemiologic Burden and Projections for Eosinophilic Esophagitis-Associated Emergency Department Visits in the United States: 2009-2030.Clin Gastroenterol Hepatol2023
36788014Gut virome-colonising <i>Orthohepadnavirus</i> genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation <i>in vivo</i>.Gut2023
36580497REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis: A Canadian IBD Research Consortium Multicenter National Cohort Study.Am J Gastroenterol2023
36645636Vedolizumab and Adalimumab in Biologic-Naïve Ulcerative Colitis: Comparison of Patient-Level Clinical Trial Data and VARSITY for Week 6 Clinical Remission.Dig Dis Sci2023
36436154An Expert Consensus to Standardize Assessment of Bowel Cleansing for Clinical Trials of Bowel Preparations for Crohn's Disease.Dig Dis Sci2023
36738443Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions.J Crohns Colitis2023
36536208Risk minimization of JAK inhibitors in ulcerative colitis following regulatory guidance.Nat Rev Gastroenterol Hepatol2023
36735555Management of Patients With Acute Lower Gastrointestinal Bleeding: An Updated ACG Guideline.Am J Gastroenterol2023
36825479Meta-analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control arm.Aliment Pharmacol Ther2023
36757156Patients With Crohn's Disease and Permanent Ileostomy Are Universally Excluded From Clinical Trials: A Systematic Review.Am J Gastroenterol2023
36271904Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn's Disease: A Systematic Review and Meta-Analysis.J Crohns Colitis2023
  • 1 - 50 of 336

Recommended Authors

Donevan Westerveld
New York-Presbyterian Hospital/Weill Cornell Medicine
Career Start Year 2014
Number of shared co-authors 0
Sunhee Park
University of California Irvine
Career Start Year 2014
Number of shared co-authors 12
Terrence C Lee
University of California San Diego
Career Start Year 2013
Number of shared co-authors 0
Vivek A Rudrapatna
University of California san francisco
Career Start Year 2012
Number of shared co-authors 12
Phillip Gu
Cedars-Sinai Medical Center
Career Start Year 2012
Number of shared co-authors 11
Christina Ha
Cedars-Sinai Medical Center
Career Start Year 2009
Number of shared co-authors 16
Rafia Bhore
Regeneron Pharmaceuticals
Career Start Year 2009
Number of shared co-authors 0
Joseph J Larson
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2009
Number of shared co-authors 4
Brendan Boyle
Nationwide Children's Hospital
Career Start Year 2009
Number of shared co-authors 3
Shailja C Shah
University of California San Diego, Veterans Affairs San Diego Healthcare System
Career Start Year 2009
Number of shared co-authors 6
Jessica J Lee
Center for Drug Evaluation and Research
Career Start Year 2006
Number of shared co-authors 1
Daniel J Stein
Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 1
Jenny Sauk
university of california los angeles School of Medicine
Career Start Year 2004
Number of shared co-authors 18
Martijn G H van Oijen
University of Amsterdam, Cancer Center Amsterdam
Career Start Year 2004
Number of shared co-authors 1
Harry Sokol
Paris Center for Microbiome Medicine
Career Start Year 2004
Number of shared co-authors 4
Ashish Atreja
Icahn School of Medicine at Mount Sinai
Career Start Year 2003
Number of shared co-authors 9
Zubair Khan
University of Texas at Houston Health Science Center
Career Start Year 2002
Number of shared co-authors 1
Elie Aoun
Columbia University
Career Start Year 2002
Number of shared co-authors 3
Nimisha K Parekh
University of California Irvine
Career Start Year 2001
Number of shared co-authors 15
Gil Y Melmed
F. Widjaja Inflammatory Bowel Disease Institute
Career Start Year 2001
Number of shared co-authors 19
Florian Grimpen
Royal Brisbane and Women's Hospital
Career Start Year 2000
Number of shared co-authors 1
Uma Mahadevan
University of California San Francisco
Career Start Year 2000
Number of shared co-authors 17
Per Olav Vandvik
Lovisenberg Diaconal Hospital
Career Start Year 1998
Number of shared co-authors 1
Amit Rastogi
Institute of Liver Transplantation
Career Start Year 1996
Number of shared co-authors 0
Brennan M R Spiegel
Cedars-Sinai Center for Outcomes Research and Education (CS-CORE)
Career Start Year 1992
Number of shared co-authors 9
Cathie Spino
University of Michigan ann arbor
Career Start Year 1991
Number of shared co-authors 0
Susan Mallett
University College London (UCL)
Career Start Year 1990
Number of shared co-authors 1
Athos Bousvaros
Boston Children's Hospital
Career Start Year 1985
Number of shared co-authors 6
Felicity T Enders
Mayo Clinic
Career Start Year 1985
Number of shared co-authors 8
Nicholas J Talley
University of Newcastle
Career Start Year 1984
Number of shared co-authors 4

Collaborators

William J Sandborn
University of California San Diego
Co-authored papers 83
Siddharth Singh
University of California San Diego
Co-authored papers 60
Parambir S Dulai
Feinberg School of Medicine Northwestern University
Co-authored papers 54
Neeraj Narula
Farncombe Family Digestive Health Research Institute, McMaster University
Co-authored papers 30
Michael Sey
Western University
Co-authored papers 20
Bruce E Sands
Icahn School of Medicine at Mount Sinai
Co-authored papers 14
Simon J Stanworth
University of Oxford
Co-authored papers 12
Brigid S Boland
University of California
Co-authored papers 11
Corey A Siegel
Dartmouth-Hitchcock Medical Center
Co-authored papers 11
Mark A Valasek
Co-authored papers 9
Jean-Frederic Colombel
Icahn School of Medicine at Mount Sinai
Co-authored papers 8
Mayur Brahmania
Cumming School of Medicine
Co-authored papers 7
Mark S Silverberg
Co-authored papers 7
Edward V Loftus
Mayo Clinic College of Medicine and Science
Co-authored papers 6
Joel G Fletcher
Mayo Clinic
Co-authored papers 5
Dana J Lukin
Jill Roberts Center for IBD
Co-authored papers 4
Robert Hirten
Co-authored papers 4
Anouar Teriaky
Western University
Co-authored papers 4
Marla C Dubinsky
Co-authored papers 4
Nghia H Nguyen
University of California
Co-authored papers 4
Arun Swaminath
Lenox Hill Hospital
Co-authored papers 4
David Hudesman
NYU Grossman School of Medicine
Co-authored papers 4
Sunanda V Kane
Mayo Clinic
Co-authored papers 4
Ronghui Xu
University of California San Diego
Co-authored papers 4
Gary S Collins
University of Oxford
Co-authored papers 3
James A Proudfoot
Shiley Eye Institute, University of California
Co-authored papers 3
Eugenia Shmidt
University of Minnesota
Co-authored papers 3
Farhad Peerani
University of Alberta
Co-authored papers 3
John T Chang
University of California San Diego
Co-authored papers 2
Ashwin N Ananthakrishnan
Co-authored papers 2
Release 1.2